Learn how a Leading Vaccine Manufacturer Accelerated Clinical Trials with Seamless Biometrics Support.

In this exclusive case study, explore how one of India’s pioneering biopharmaceutical company, known for its commitment to low-cost vaccine production, partnered with Navitas Life Sciences to support two pivotal vaccine trials:

• Pneumococcal Polysaccharide Conjugate Vaccine (PCV)
• Typhoid Conjugate Vaccine (TCV)

Faced with stringent timelines, evolving study requirements, and complex data management needs, the client turned to Navitas for end-to-end biometrics support.

Key Highlights

Discover how Navitas Life Sciences helped overcome tight timelines, mid-study changes, and high-volume data challenges to enable faster access to life-saving vaccines.

• Rapid team onboarding to kickstart study activities
• Database setup completed four days ahead of schedule
• Mid-study modifications seamlessly implemented
• High-quality, discrepancy-free data delivery
• Proven methodologies for regulatory compliance and submission success

Get the Full Story

Learn how Navitas Life Sciences transformed challenges into success through expert planning, proactive communication, and technology-driven biometrics solutions. Fill the form and download the case study to learn more. 

© 2025 Navitas Life Sciences | Privacy Policy